Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)
Clinical trial NCT06816394 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06816394
- Sponsor
- National Taiwan University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-15
- Primary completion
- 2027-12-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.